EnteroMedics Inc (NASDAQ:ETRM) Soars on News- ETRM, SNCR, NUAN, RAD, APC

Lakeway, TX -- (SBWIRE) -- 02/08/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

EnteroMedics Inc (NASDAQ:ETRM) shares declined 4.70% to $2.84 in the pre-market hour after the company yesterday announced results from its randomized ReCharge Pivotal Trial of VBLOC vagal blocking therapy for the treatment of obesity. According to the company, the trial demonstrated a clinically meaningful and statistically significant excess weight loss of 24.4% for VBLOC Therapy-treated patients, with 52.5% of patients achieving at least 20% excess weight loss. The company said the trial met its primary safety endpoint, though it did not meet its predefined primary efficacy measures.

How Should Investors Trade ETRM After The Latest Earnings Report? Find Out Here

Synchronoss Technologies, Inc. (NASDAQ:SNCR) reported fourth-quarter net income of $3.4 million or $0.09 per share, compared to $8.2 million or $0.21 per share in the year-ago quarter. Adjusted earnings for the quarter were $11.1 million or $0.29 per share. Analysts expected the company to earn $0.25 per share. Revenues for the quarter rose to $73.18 million from $62.15 million a year ago, while analysts had a consensus revenue estimate of $70.09 million for the quarter.

Is SNCR a Buy After The Solid Earnings? Get Free Trend Analysis Here

Nuance Communications Inc. (NASDAQ:NUAN) stock fell 17.54% to $20.28 in the pre-market hour after the company yesterday reported a net loss of $22.10 million or $0.07 per share for the first quarter, compared to net income of $9.34 million or $0.03 per share in the prior-year quarter. Adjusted net income for the quarter was $112.96 million or $0.35 per share, compared to $108.55 million or $0.34 per share in the year-ago quarter. Analysts expected the company to report earnings of $0.36 per share for the quarter. Revenue grew 28.2% to $462.27 million from $360.64 million last year. Meanwhile, adjusted revenues for the quarter increased 28.9 percent to $492.42 million from $382.05 million in the same quarter last year, and analysts' consensus estimate.

How Should Investors Trade NUAN After The Recent Movement? Find Out Here

Rite Aid Corporation (NYSE:RAD) stock declined 1.19% to $1.66 in the pre-market hour. Fitch Ratings has assigned a rating of 'BB-/RR1' to Rite Aid Corporation's (Rite Aid) proposed new $1.725 billion secured revolving credit facility due 2018, $900 million senior secured term loan B due 2020, and $470 senior secured second lien term loan due 2020. The Rating Outlook is Stable.

Get Latest News, Updates and Reports For Free On RAD Here

Anadarko Petroleum Corporation (NYSE:APC), on Feb. 4, posted a fourth-quarter profit, as rising production helped offset lower prices for natural gas and oil. The company earned $203 million, or 40 cents per share, for the quarter that ended Dec. 31. Adjusted profit would have been $457 million or 91 cents per share. Analysts expected a profit of 72 cents per share. Revenue fell 11.2 percent to $3.41 billion _ a little more than analysts had expected _ from $3.84 billion a year ago.

How Should Investors Trade APC After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.